tetano
Editor, Senior Moderator
J Infect Chemother
. 2023 Apr 12;S1341-321X(23)00096-X.
doi: 10.1016/j.jiac.2023.04.005. Online ahead of print.
Factors affecting the sensitivity of quantitative severe acute respiratory syndrome coronavirus 2 antigen test
Yuki Sato[SUP] 1 [/SUP], Ryosei Murai[SUP] 2 [/SUP], Ryo Kobayashi[SUP] 1 [/SUP], Atsuo Togashi[SUP] 3 [/SUP], Yoshihiro Fujiya[SUP] 4 [/SUP], Koji Kuronuma[SUP] 5 [/SUP], Satoshi Takahashi[SUP] 6 [/SUP]
Affiliations
Abstract
Introduction: The accuracy of nucleic acid amplification tests (NAATs) is affected by various factors; however, studies examining the factors affecting the accuracy of quantitative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen test (QAT) are limited.
Methods: A total of 347 nasopharyngeal samples were collected from patients with coronavirus disease 2019 (COVID-19), and the date of onset was obtained from the electronic medical records. The SARS-CoV-2 antigen level was measured using Lumipulse Presto SARS-CoV-2 Ag (Presto), while NAAT was performed using the Ampdirect 2019-nCoV Detection Kit.
Results: Presto had a sensitivity rate of 95.1% (95% confidence interval: 92.8-97.4) in detecting the SARS-CoV-2 antigen in 347 samples. The number of days from symptom onset to sample collection was negatively correlated with the amount of antigen (r = -0.515) and sensitivity of Presto (r = -0.711). The patients' age was lower in the Presto-negative samples (median age, 39 years) compared with that in the Presto-positive samples (median age, 53 years; p < 0.01). A significant positive correlation was observed between age (excluding teenagers) and Presto sensitivity (r = 0.764). Meanwhile, no association was found between the mutant strain, sex, and Presto results.
Conclusion: Presto is useful for the accurate diagnosis of COVID-19 owing to its high sensitivity when the number of days from symptom onset to sample collection is within 12 days. Furthermore, age may affect the results of Presto, and this tool has a relatively low sensitivity in younger patients.
Keywords: Chemiluminescent enzyme immunoassay system; Days from onset; Quantitative SARS-CoV-2 antigen test; SARS-CoV-2; Sensitivity.
. 2023 Apr 12;S1341-321X(23)00096-X.
doi: 10.1016/j.jiac.2023.04.005. Online ahead of print.
Factors affecting the sensitivity of quantitative severe acute respiratory syndrome coronavirus 2 antigen test
Yuki Sato[SUP] 1 [/SUP], Ryosei Murai[SUP] 2 [/SUP], Ryo Kobayashi[SUP] 1 [/SUP], Atsuo Togashi[SUP] 3 [/SUP], Yoshihiro Fujiya[SUP] 4 [/SUP], Koji Kuronuma[SUP] 5 [/SUP], Satoshi Takahashi[SUP] 6 [/SUP]
Affiliations
- PMID: 37059393
- PMCID: PMC10098054
- DOI: 10.1016/j.jiac.2023.04.005
Abstract
Introduction: The accuracy of nucleic acid amplification tests (NAATs) is affected by various factors; however, studies examining the factors affecting the accuracy of quantitative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen test (QAT) are limited.
Methods: A total of 347 nasopharyngeal samples were collected from patients with coronavirus disease 2019 (COVID-19), and the date of onset was obtained from the electronic medical records. The SARS-CoV-2 antigen level was measured using Lumipulse Presto SARS-CoV-2 Ag (Presto), while NAAT was performed using the Ampdirect 2019-nCoV Detection Kit.
Results: Presto had a sensitivity rate of 95.1% (95% confidence interval: 92.8-97.4) in detecting the SARS-CoV-2 antigen in 347 samples. The number of days from symptom onset to sample collection was negatively correlated with the amount of antigen (r = -0.515) and sensitivity of Presto (r = -0.711). The patients' age was lower in the Presto-negative samples (median age, 39 years) compared with that in the Presto-positive samples (median age, 53 years; p < 0.01). A significant positive correlation was observed between age (excluding teenagers) and Presto sensitivity (r = 0.764). Meanwhile, no association was found between the mutant strain, sex, and Presto results.
Conclusion: Presto is useful for the accurate diagnosis of COVID-19 owing to its high sensitivity when the number of days from symptom onset to sample collection is within 12 days. Furthermore, age may affect the results of Presto, and this tool has a relatively low sensitivity in younger patients.
Keywords: Chemiluminescent enzyme immunoassay system; Days from onset; Quantitative SARS-CoV-2 antigen test; SARS-CoV-2; Sensitivity.